BioVectra wins contract to make Prolanta for trials
Canadian biologics CMO BioVectra has been contracted to make trial supplies of the candidate cancer treatment Prolanta by US biopharmaceutical firm Oncolix.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs